CDK2 and ovarian carcinoma: Nevertheless, taken together, our data not only show alterations in sub-cellular localisation but also demonstrate the predictive and/or prognostic significance of the cyclin D1/E1–CDK2/4/6–RB1 pathway in ovarian cancer.